Xenetic Biosciences (XBIO): Net Assets per Single Share

Graphic logo of Xenetic Biosciences (XBIO)

Xenetic Biosciences (XBIO) is developing biopharmaceutical platforms to optimize the delivery of oncology drugs, leveraging a compact staff of top-tier researchers. The book value per share forecast illustrates net asset dynamics, with 2.60 serving as the current metric level. Capitalization is based on the sale of DNase enzyme technologies to major medical centers and pharmaceutical behemoths to improve patient survival rates.

XBIO (Xenetic Bio) Accounting Value per Share history from 07/04/2022 to 10/30/2026

Financial and market metric breakdowns for Xenetic Biosciences Inc. (XBIO)

- stock price and consensus target price:
Stock Price Xenetic Bio|XBIO - Analyst Median Target
- stock exchange capitalization data:
Market Value Xenetic Biosciences, Inc.|XBIO - Total Enterprise Value
- shareholders' equity book value data:
Book Value per Share Xenetic Biosciences|XBIO - Company Net Assets|Market Capitalization to Book Value Ratio xeneticbio.com|XBIO - Company Total Assets
- debt and liquidity details:
Debt to Equity Xenetic Biosciences|XBIO - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Xenetic Bio|XBIO - Company Total Debt|Debts to Book Capitalization Xenetic Biosciences, Inc.|XBIO - Long-Term Debt|Company Short-Term Debt Xenetic Biosciences|Quick Liquidity Indicator xeneticbio.com
- net income and valuation multiples indicators:
XBIO - Final Profit
Initial company analysis:xeneticbio.com (XBIO)
Mass-produced product of Xenetic Biosciences Inc.

Book value per share reflects the portion of equity attributable to a single security and serves as a measure of the real value of assets minus liabilities. By analyzing the historical trend of book value per share, an investor assesses the financial stability of Xenetic Biosciences (XBIO) amid the capital-intensive development of biologics and the prolonged safety trials of its oncological drug delivery platforms.

Main competitors

BeiGene Corp - Book Value per Share|Net Assets per Share Halozyme Corp HALO|Revolution Medicines (RVMD) - Net Assets per Single Share|Net Asset Value per Share ascentage.com (AAPG)|CGON (CG Oncology) - Book Value per Share|Accounting Value per Share UroGen Pharma Ltd (URGN)|Book Value per Share BCAX|Book Value per Share Personalis Genomics (PSNL)|Net Assets per Single Share Erasca, Inc. ERAS|DCTH: Equity per Share|Y-mAbs Therapeutics, Inc. - Book Value per Share|Aura Biosciences Inc (AURA) - Accounting Value per Share|CADL: Book Value per Share|Net Asset Value per Share Accuray, Inc. (ARAY)|Net Assets per Single Share SELLAS Life Sciences Group, Inc.|ACTU: Accounting Value of a Share|Accounting Value per Share CTOR (Citius Oncology)|HURA (tuhurabio.com) - Accounting Value of a Share|Book Value per Share TARA (Protara)|FATE - Accounting Value per Share|WHWK: Accounting Value per Share|TCRX - Book Value per Share|championsoncology.com (CSBR) - Net Assets per Single Share|XBiotech - Accounting Value of a Share|CVM (CEL-SCI Corp.) - Book Value per Share|Net Asset Value per Share OS Therapies, Inc. OSTX|Accounting Value per Share RADX (Radiopharm Theranostics Limited)|artivabio.com - Equity per Share|Book Value per Share ANL (Adlai Nortye)|Veru Inc (VERU) - Net Asset Value per Share|TPST - Net Assets per Single Share|XLO (Xilio Therapeutics, Inc.) - Equity per Share|RENB: Book Value per Share|Net Asset Value per Share Mural Oncology (MURA)|Accounting Value per Share KAPA|OKUR (OnKure) - Book Price of a Share|Book Value per Share GDTC|Net Assets per Share curis.com|Book Value per Share APLM (Apollomics)|THAR - Accounting Value per Share|ADVB: Accounting Value per Share|Accounting Value of a Share GNPX (Genprex Inc.)|CLDI: Book Value per Share|SBFM (Sunshine Biopharma Inc.) - Net Assets per Single Share|SLRX (Salarius Pharmaceuticals) - Book Value per Share|purple-biotech.com (PPBT) - Net Assets per Share|Net Assets per Single Share American Oncology Network (AONC)|BGNE - Net Asset Value per Share|Net Assets per Single Share Checkpoint Therapeutics, Inc CKPT|Net Assets per Share elevationoncology.com (ELEV)|iCAD Corp - Book Value per Share|Ikena Oncology, Inc. (IKNA) - Accounting Value per Share|NTBL: Book Value per Share|VIRX - Net Assets per Share|MOR (MorphoSys Corp) - Book Value per Share|Net Asset Value per Share NAYA Biosciences Corp NAYA|Net Assets per Single Share Ascentage Pharma Group (AAPGV)